Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 26;19(1):153.
doi: 10.1186/s12985-022-01881-4.

Traces of JC polyomavirus in papillary thyroid cancer: a comprehensive study in Iran

Affiliations

Traces of JC polyomavirus in papillary thyroid cancer: a comprehensive study in Iran

Amir Ali Karimi et al. Virol J. .

Abstract

Background: JC polyomavirus (JCPyV) is known to induce solid tumors such as astrocytomas, glioblastomas, and neuroblastomas in experimental animals, and recent studies have shown that the virus may be correlated with carcinogenesis. This study aimed to evaluate the impact of JCPyV on the progression of papillary thyroid cancer (PTC).

Methods: A total of 1057 samples, including 645 paraffin-embedded PTC biopsy samples (PEBS) and 412 fresh biopsy samples (FBS), and 1057 adjacent non-cancerous samples were evaluated for the presence of JCPyV DNA and RNA.

Results: We observed that 10.8% (114/1057) samples, including 17.5% (72/412) FBS and 6.5% (42/645) PEBS were positive for the JCPyV DNA. Among the JCPyV-positive samples, the mean JCPyV copy number was lower in patients with PEBS (0.3 × 10-4 ± 0.1 × 10-4 copies/cell) compared to FBS (1.8 × 10-1 ± 0.4 × 10-1 copies/cell) and non-PTC normal samples (0.2 × 10-5 ± 0.01 × 10-5 copies/cell), with a statistically significant difference (P < 0.001). The LT-Ag RNA expression was lower in PEBS than in FBS, while no VP1 gene transcript expression was found.

Conclusions: Although our results confirmed the presence of JCPyV in some Iranian patients with PTC, more research is needed to verify these results.

Keywords: JCPyV; Non-cancerous sample; Papillary thyroid cancer.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Similar articles

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Crnčić TB, Tomaš MI, Girotto N, Ivanković SG. Risk factors for thyroid cancer: What do we know so far? Acta Clin Croat. 2020;59:66. - PMC - PubMed
    1. Mostafaei S, Keshavarz M, Nahand JS, Hassankiadeh RF, Moradinazar M, Nouri M, Babaei F, Ahadi M, Payandeh M, Esker AS. Viral infections and risk of thyroid Cancer: a systematic review and empirical Bayesian meta-analysis. Pathol Res Pract. 2020;216:152855. doi: 10.1016/j.prp.2020.152855. - DOI - PubMed
    1. Ghanghareh M, Mosayebi Amroabadi J, Tavangar SM, Irani S, Sakhaee F, Ghazanfari Jajin M, Vaziri F, Siadat SD, Fateh A. Evidencing the presence of merkel cell polyomavirus in papillary thyroid cancer. Sci Rep. 2021;11:1–6. doi: 10.1038/s41598-021-01055-2. - DOI - PMC - PubMed
    1. Tan CS, Ghofrani J, Geiger E, Koralnik IJ, Jost S. Decreased JC virus-specific antibody-dependent cellular cytotoxicity in HIV-seropositive PML survivors. J Acquir Immune Defic Syndr. 1999;2019(82):220. - PMC - PubMed